Serhiy Hnatyshyn
Advertisement
Articles by Serhiy Hnatyshyn
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Next-Generation Modalities Drive New Antibody Discovery
2
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
3
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
4
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
5